In Rheumatology, we have more bits of information about our patients with chronic diseases than we can manage, without help. Just one visit, for example, generates results of tests and […]
Our Patient-Reported Outcomes Measurement Information System-Physical Function (PROMIS PF) Minimal Disease Activity (MDA), a tool developed at Johns Hopkins and validated within our PsA cohort, allows for exquisite description of […]
In 2015, Johns Hopkins scientists proved that scleroderma is often a casualty of war: it is the unfortunate consequence of the body’s battle to fight off cancer. We have since […]
Despite a very difficult year for all of us, remarkable things are being accomplished at Johns Hopkins Rheumatology, and I hope you will see that this issue of LEAP is […]
The vast majority of the patients who take statins don’t ever have to worry about the side effect of muscle symptoms. Even among those who do experience muscle damage, with […]
A prevalent belief among rheumatologists has been that an accurate diagnosis of Sjögren’s is not essential because of the lack of disease-modifying therapies. But a correct diagnosis is very important […]